HPE
75
7
AON
62
-5
NWSA
64
-15
RIG
40
2
CFG
95
2
MRK
63
3
MTB
73
4
AMG
77
3
HBAN
82
3
KIM
50
-3
A
43
-5
DTE
38
-4
ACN
56
2
TAP
29
-11
AEP
61
-3
UHS
55
3
HRL
23
-12
PLD
30
2
DG
74
2
CNX
49
3
HPE
75
7
AON
62
-5
NWSA
64
-15
RIG
40
2
CFG
95
2
MRK
63
3
MTB
73
4
AMG
77
3
HBAN
82
3
KIM
50
-3
A
43
-5
DTE
38
-4
ACN
56
2
TAP
29
-11
AEP
61
-3
UHS
55
3
HRL
23
-12
PLD
30
2
DG
74
2
CNX
49
3
Financhill
Back

Invesco BulletShares 2031 Corporate Bond ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison

Buy
80

BSCV
Invesco BulletShares 2031 Corporate Bond ETF

Last Price:
$16.73
Seasonality Move:
3.43%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$55.85
Seasonality Move:
14.46%
Buy
80
Invesco BulletShares 2031 Corporate Bond ETF (BSCV) is a Buy

Is Invesco BulletShares 2031 Corporate Bond ETF a Buy, Sell or Hold?

  • The current Invesco BulletShares 2031 Corporate Bond ETF [BSCV] share price is $16.73. The Score for BSCV is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • BSCV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BSCV Stock Price Chart

What is Invesco BulletShares 2031 Corporate Bond ETF's stock price today?

  • The Invesco BulletShares 2031 Corporate Bond ETF share price today is $16.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BSCV is experiencing slight selling pressure.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $55.86
    The current trend is relatively stagnant and CRSP is experiencing slight buying pressure.

BSCV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 53.18 Buy
Chaikin Money Flow: -628497 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.67 - 16.73) Buy
Bollinger Bands (100): (16.62 - 16.76) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 49.16 Sell
Chaikin Money Flow: 78181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.94 - 57.06) Buy
Bollinger Bands (100): (52.44 - 65.4) Sell

BSCV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.71 Buy
20-day SMA: 16.71 Buy
50-day SMA: 16.71 Buy
200-day SMA: 16.5 Buy
8-day EMA: 16.71 Buy
20-day EMA: 16.7 Buy
50-day EMA: 16.7 Buy
200-day EMA: 16.55 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.25 Sell
20-day SMA: 55.05 Buy
50-day SMA: 58.96 Sell
200-day SMA: 51.1 Buy
8-day EMA: 55.79 Buy
20-day EMA: 55.79 Buy
50-day EMA: 56.36 Sell
200-day EMA: 37.56 Buy

Invesco BulletShares 2031 Corporate Bond ETF Earnings Growth & BSCV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

Invesco BulletShares 2031 Corporate Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):